Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shintaro Hirata

Showing results (61-70 of 151) with videos related to

Pageof 16
Sort By:
Arthritis Research & Therapy|February 14, 2020
Tumour necrosis factor alpha promotes secretion of 14-3-3η by inducing necroptosis in macrophagesGulzhan Trimova, Kaoru Yamagata, Shigeru Iwata, et al.
Modern Rheumatology|February 14, 2016
Association of the multi-biomarker disease activity score with joint destruction in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha inhibitor treatment in clinical practiceShintaro Hirata, Wanying Li, Satoshi Kubo, et al.
Scientific Reports|October 12, 2021
Capsule endoscopy findings reflect the gastrointestinal conditions of patients with systemic sclerosisSumio Iio, Shiro Oka, Shinji Tanaka, et al.
Clinical and Experimental Rheumatology|January 24, 2020
Serum CXCL10 levels are associated with better responses to abatacept treatment of rheumatoid arthritisKazutoshi Yukawa, Sho Mokuda, Hiroki Kohno, et al.
Modern Rheumatology Case Reports|September 28, 2020
Immunoglobulin D-kappa multiple myeloma in a patient with rheumatoid arthritis: a case report and review of the literatureTadahiro Tokunaga, Hiroo Hashimoto, Yusuke Yoshida, et al.
Plos One|May 19, 2025
Protocol: Filgotinib in addition to methotrexate versus filgotinib monotherapy in patients with rheumatoid arthritis with an inadequate response to methotrexate: A multicenter, prospective, open-label, randomized controlled trial (FAITHFUL Study)Mitsuhiro Akiyama, Toshihiko Hidaka, Motohide Kaneko, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 20, 2022
[A Case of Colitic Cancer with a Total Proctocolectomy in the Second Term]Masatoshi Yoshizawa, Masahiro Amano, Shintaro Hirata, et al.
Clinical Rheumatology|June 5, 2026
Effect of different folic acid doses on methotrexate-related toxicity and its association with erythrocyte methotrexate-polyglutamates in patients with rheumatic diseases: a single-center exploratory randomized controlled trialYusuke Yoshida, Yohei Hosokawa, Takanori Taogoshi, et al.
Internal Medicine (Tokyo, Japan)|July 12, 2019
Non-small Cell Lung Cancer Treated by an Anti-programmed Cell Death-1 Antibody without a Flare-up of Preexisting Granulomatosis with PolyangiitisTakahiro Yamada, Takeshi Masuda, Kakuhiro Yamaguchi, et al.
Modern Rheumatology|August 21, 2020
Lower CH50 as a predictor for intractable or recurrent lupus enteritis: A retrospective observational studyYusuke Yoshida, Takuji Omoto, Hiroki Kohno, et al.
Pageof 16

Showing results (61-70 of 151) with videos related to

Sort By:
Pageof 16
Arthritis Research & Therapy|February 14, 2020
Tumour necrosis factor alpha promotes secretion of 14-3-3η by inducing necroptosis in macrophagesGulzhan Trimova, Kaoru Yamagata, Shigeru Iwata, et al.
Modern Rheumatology|February 14, 2016
Association of the multi-biomarker disease activity score with joint destruction in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha inhibitor treatment in clinical practiceShintaro Hirata, Wanying Li, Satoshi Kubo, et al.
Scientific Reports|October 12, 2021
Capsule endoscopy findings reflect the gastrointestinal conditions of patients with systemic sclerosisSumio Iio, Shiro Oka, Shinji Tanaka, et al.
Clinical and Experimental Rheumatology|January 24, 2020
Serum CXCL10 levels are associated with better responses to abatacept treatment of rheumatoid arthritisKazutoshi Yukawa, Sho Mokuda, Hiroki Kohno, et al.
Modern Rheumatology Case Reports|September 28, 2020
Immunoglobulin D-kappa multiple myeloma in a patient with rheumatoid arthritis: a case report and review of the literatureTadahiro Tokunaga, Hiroo Hashimoto, Yusuke Yoshida, et al.
Plos One|May 19, 2025
Protocol: Filgotinib in addition to methotrexate versus filgotinib monotherapy in patients with rheumatoid arthritis with an inadequate response to methotrexate: A multicenter, prospective, open-label, randomized controlled trial (FAITHFUL Study)Mitsuhiro Akiyama, Toshihiko Hidaka, Motohide Kaneko, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 20, 2022
[A Case of Colitic Cancer with a Total Proctocolectomy in the Second Term]Masatoshi Yoshizawa, Masahiro Amano, Shintaro Hirata, et al.
Clinical Rheumatology|June 5, 2026
Effect of different folic acid doses on methotrexate-related toxicity and its association with erythrocyte methotrexate-polyglutamates in patients with rheumatic diseases: a single-center exploratory randomized controlled trialYusuke Yoshida, Yohei Hosokawa, Takanori Taogoshi, et al.
Internal Medicine (Tokyo, Japan)|July 12, 2019
Non-small Cell Lung Cancer Treated by an Anti-programmed Cell Death-1 Antibody without a Flare-up of Preexisting Granulomatosis with PolyangiitisTakahiro Yamada, Takeshi Masuda, Kakuhiro Yamaguchi, et al.
Modern Rheumatology|August 21, 2020
Lower CH50 as a predictor for intractable or recurrent lupus enteritis: A retrospective observational studyYusuke Yoshida, Takuji Omoto, Hiroki Kohno, et al.
Pageof 16